Correlation Between DXC Technology and Diamyd Medical

Can any of the company-specific risk be diversified away by investing in both DXC Technology and Diamyd Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DXC Technology and Diamyd Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DXC Technology Co and Diamyd Medical AB, you can compare the effects of market volatilities on DXC Technology and Diamyd Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DXC Technology with a short position of Diamyd Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of DXC Technology and Diamyd Medical.

Diversification Opportunities for DXC Technology and Diamyd Medical

-0.42

Correlation Coefficient

DXC Technology  Diamyd Medical

Very good diversification

The 3 months correlation between DXC and Diamyd is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding DXC Technology Co and Diamyd Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diamyd Medical AB and DXC Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DXC Technology Co are associated (or correlated) with Diamyd Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diamyd Medical AB has no effect on the direction of DXC Technology i.e., DXC Technology and Diamyd Medical go up and down completely randomly.

Pair Corralation between DXC Technology and Diamyd Medical

Assuming the 90 days trading horizon DXC Technology Co is expected to under-perform the Diamyd Medical. In addition to that, DXC Technology is 1.15 times more volatile than Diamyd Medical AB. It trades about -0.28 of its total potential returns per unit of risk. Diamyd Medical AB is currently generating about -0.26 per unit of volatility. If you would invest  149.00  in Diamyd Medical AB on November 29, 2024 and sell it today you would lose (17.00) from holding Diamyd Medical AB or give up 11.41% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

DXC Technology Co  vs.  Diamyd Medical AB

DXC Technology

Risk-Adjusted Performance

Very Weak

Over the last 90 days DXC Technology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Diamyd Medical AB

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Diamyd Medical AB are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Diamyd Medical reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with DXC Technology and Diamyd Medical

The main advantage of trading using opposite DXC Technology and Diamyd Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DXC Technology position performs unexpectedly, Diamyd Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diamyd Medical will offset losses from the drop in Diamyd Medical's long position.

The idea behind DXC Technology Co and Diamyd Medical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.